Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Kucharova, Karolina ^a   Chang, Yunchao ^a,b   Boor, Andrej ^c   Yong, Voon W ^d   Stallcup, William B ^a  

^a BURNHAM INSTITUTE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c P J AFÁRIK UNIVERSITY   (Slovakia)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Inflammation; Macrophages; Myelin repair; Ng2 ablation; Oligodendrocyte progenitors; Pericytes

Indexed keywords

BROXURIDINE; CYTOKINE; PROTEOGLYCAN; PROTEOGLYCAN NG2; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; ANTIGEN; CALCIUM BINDING PROTEIN; CHONDROITIN SULFATE PROTEOGLYCAN 4; LYSOPHOSPHATIDYLCHOLINE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DEMYELINATION; DISEASE ASSOCIATION; DISEASE COURSE; INFLAMMATION; MACROPHAGE; MICROGLIA; MOUSE; MYELIN SHEATH; NERVE CELL LESION; NERVE REGENERATION; NONHUMAN; OLIGODENDROGLIA; PERICYTE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REMYELINIZATION; SPINAL CORD; STEM CELL; WILD TYPE; ANIMAL; CELL MOTION; CYTOLOGY; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; MULTIPLE SCLEROSIS; PATHOLOGY; PHYSIOLOGY; REGENERATION;

ANIMALS; ANTIGENS; CALCIUM-BINDING PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CYTOKINES; INFLAMMATION; LYSOPHOSPHATIDYLCHOLINES; MACROPHAGES; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; MICROGLIA; MULTIPLE SCLEROSIS; MYELIN SHEATH; PROTEOGLYCANS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; REGENERATION; SPINAL CORD;

EID: 81055149915     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-158     Document Type: Article

References (58)

1. Grigoriadis N, Grigoriadis S, Polyzoidou E, Milonas I, Karussis D. Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction. Clin Neurol Neurosurg 2006, 108:241-244. 10.1016/j.clineuro.2005.11.006, 16388896.
2. Mikita J, Dubourdieu-Cassagno N, Deloire MS, Vekris A, Biran M, Raffard G, Brochet B, Canron MH, Franconi JM, Boiziau C, Petry KG. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler 2011, 17:2-15. 10.1177/1352458510379243, 20813772.
3. Petry KG, Brochet B, Dousset V, Vignes JR, Boiziau C. Inflammation induced neurological handicap processes in multiple sclerosis: new insights from preclinical studies. J Neural Transm 2010, 117:907-917. 10.1007/s00702-010-0432-5, 20571836.
4. Ousman SS, David S. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 2000, 30:92-104. 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W, 10696148.
5. Rosenberg GA. Matrix metalloproteinases and neuroinflammation in multiple sclerosis. Neuroscientist 2002, 8:586-595. 10.1177/1073858402238517, 12467380.
6. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ, Stiles CD. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 2004, 306:2111-2115. 10.1126/science.1103709, 15604411.
7. Dawson MR, Levine JM, Reynolds R. NG2-expressing cells in the central nervous system: are they oligodendroglial progenitors?. J Neurosci Res 2000, 61:471-479. 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.0.CO;2-N, 10956416.
8. Gensert JM, Goldman JE. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 1997, 19:197-203. 10.1016/S0896-6273(00)80359-1, 9247275.
9. Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, Winkler J, Thal LJ, Gage FH. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 2000, 20:2218-2228.
10. Keirstead HS, Blakemore WF. Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J Neuropathol Exp Neurol 1997, 56:1191-1201. 10.1097/00005072-199711000-00003, 9370229.
11. Nguyen L, Borgs L, Vandenbosch R, Mangin JM, Beukelaers P, Moonen G, Gallo V, Malgrange B, Belachew S. The Yin and Yang of cell cycle progression and differentiation in the oligodendroglial lineage. Ment Retard Dev Disabil Res Rev 2006, 12:85-96. 10.1002/mrdd.20103, 16807909.
12. Patel JR, McCandless EE, Dorsey D, Klein RS. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci USA 2010, 107:11062-11067. 10.1073/pnas.1006301107, 2890706, 20534485.
13. Nishiyama A, Watanabe M, Yang Z, Bu J. Identity, distribution, and development of polydendrocytes: NG2-expressing glial cells. J Neurocytol 2002, 31:437-455. 10.1023/A:1025783412651, 14501215.
14. Butt AM, Duncan A, Hornby MF, Kirvell SL, Hunter A, Levine JM, Berry M. Cells expressing the NG2 antigen contact nodes of Ranvier in adult CNS white matter. Glia 1999, 26:84-91. 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.0.CO;2-L, 10088675.
15. Butt AM, Kiff J, Hubbard P, Berry M. Synantocytes: new functions for novel NG2 expressing glia. J Neurocytol 2002, 31:551-565. 10.1023/A:1025751900356, 14501223.
16. Ong WY, Levine JM. A light and electron microscopic study of NG2 chondroitin sulfate proteoglycan-positive oligodendrocyte precursor cells in the normal and kainate-lesioned rat hippocampus. Neuroscience 1999, 92:83-95. 10.1016/S0306-4522(98)00751-9, 10392832.
17. Lin SC, Bergles DE. Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus. Nat Neurosci 2004, 7:24-32. 10.1038/nn1162, 14661022.
18. Paukert M, Bergles DE. Synaptic communication between neurons and NG2+ cells. Curr Opin Neurobiol 2006, 16:515-521. 10.1016/j.conb.2006.08.009, 16962768.
19. Blakemore WF, Franklin RJ. Remyelination in experimental models of toxin-induced demyelination. Curr Top Microbiol Immunol 2008, 318:193-212. 10.1007/978-3-540-73677-6_8, 18219819.
20. Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, Sorensen PS, Laursen H. Demyelination versus remyelination in progressive multiple sclerosis. Brain 2010, 133:2983-2998. 10.1093/brain/awq250, 20855416.
21. Franklin RJ. Why does remyelination fail in multiple sclerosis?. Nat Rev Neurosci 2002, 3:705-714. 10.1038/nrn917, 12209119.
22. Stallcup WB. The NG2 proteoglycan: past insights and future prospects. J Neurocytol 2002, 31:423-435. 10.1023/A:1025731428581, 14501214.
23. Stallcup WB, Huang FJ. A role for the NG2 proteoglycan in glioma progression. Cell Adh Migr 2008, 2:192-201. 10.4161/cam.2.3.6279, 2634088, 19262111.
24. Kucharova K, Stallcup WB. The NG2 proteoglycan promotes oligodendrocyte progenitor proliferation and developmental myelination. Neuroscience 2010, 166:185-194. 10.1016/j.neuroscience.2009.12.014, 2847446, 20006679.
25. Ozerdem U, Stallcup WB. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. Angiogenesis 2004, 7:269-276. 10.1007/s10456-004-4182-6, 1350818, 15609081.
26. Huang FJ, You WK, Bonaldo P, Seyfried TN, Pasquale EB, Stallcup WB. Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse. Dev Biol 2010, 344:1035-1046. 10.1016/j.ydbio.2010.06.023, 3197744, 20599895.
27. Grako KA, Ochiya T, Barritt D, Nishiyama A, Stallcup WB. PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse. J Cell Sci 1999, 112(Pt 6):905-915.
28. Ozerdem U, Grako KA, Dahlin-Huppe K, Monosov E, Stallcup WB. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn 2001, 222:218-227. 10.1002/dvdy.1200, 11668599.
29. de Castro R, Tajrishi R, Claros J, Stallcup WB. Differential responses of spinal axons to transection: influence of the NG2 proteoglycan. Exp Neurol 2005, 192:299-309. 10.1016/j.expneurol.2004.11.027, 15755547.
30. Kiernan JA. Histological and Histochemical Methods: Theory and Practice 1999, Butterworth-Heinemann, Oxford, 3.
31. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35. 10.1038/nri978, 12511873.
32. Watanabe M, Toyama Y, Nishiyama A. Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J Neurosci Res 2002, 69:826-836. 10.1002/jnr.10338, 12205676.
33. Piaton G, Williams A, Seilhean D, Lubetzki C. Remyelination in multiple sclerosis. Prog Brain Res 2009, 175:453-464.
34. Miron VE, Kuhlmann T, Antel JP. Cells of the oligodendroglial lineage, myelination, and remyelination. Biochim Biophys Acta 2011, 1812:184-193.
35. Gregson NA. Lysolipids and membrane damage: lysolecithin and its interaction with myelin. Biochem Soc Trans 1989, 17:280-283.
36. Hall SM. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci 1972, 10:535-546.
37. Blakemore WF, Eames RA, Smith KJ, McDonald WI. Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin. J Neurol Sci 1977, 33:31-43. 10.1016/0022-510X(77)90179-4, 903788.
38. Cristofanilli M, Harris VK, Zigelbaum A, Goossens AM, Lu A, Rosenthal H, Sadiq SA. Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice. Stem Cells Dev
39. Pohl HB, Porcheri C, Mueggler T, Bachmann LC, Martino G, Riethmacher D, Franklin RJ, Rudin M, Suter U. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J Neurosci 2011, 31:1069-1080. 10.1523/JNEUROSCI.5035-10.2011, 21248132.
40. Yong VW. Inflammation in neurological disorders: a help or a hindrance?. Neuroscientist 2010, 16:408-420. 10.1177/1073858410371379, 20817918.
41. Yaguchi M, Ohta S, Toyama Y, Kawakami Y, Toda M. Functional recovery after spinal cord injury in mice through activation of microglia and dendritic cells after IL-12 administration. J Neurosci Res 2008, 86:1972-1980. 10.1002/jnr.21658, 18438913.
42. Watzlawik J, Warrington AE, Rodriguez M. Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination. Expert Rev Neurother 2010, 10:441-457. 10.1586/ern.10.13, 2842090, 20187865.
43. Holley JE, Newcombe J, Whatmore JL, Gutowski NJ. Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter. Neurosci Lett 2009, 470:65-70.
44. Kirk S, Frank JA, Karlik S. Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon?. J Neurol Sci 2004, 217:125-130. 10.1016/j.jns.2003.10.016, 14706213.
45. Roscoe WA, Welsh ME, Carter DE, Karlik SJ. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. J Neuroimmunol 2009, 209:6-15. 10.1016/j.jneuroim.2009.01.009, 19233483.
46. Caplan AI. All MSCs are pericytes?. Cell Stem Cell 2008, 3:229-230. 10.1016/j.stem.2008.08.008, 18786406.
47. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3:301-313. 10.1016/j.stem.2008.07.003, 18786417.
48. Siatskas C, Payne NL, Short MA, Bernard CC. A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it's time!. Stem Cell Rev 2010, 6:500-506. 10.1007/s12015-010-9173-y, 20665128.
49. Kadoya K, Fukushi J, Matsumoto Y, Yamaguchi Y, Stallcup WB. NG2 proteoglycan expression in mouse skin: altered postnatal skin development in the NG2 null mouse. J Histochem Cytochem 2008, 56:295-303. 2324176, 18040080.
50. Makagiansar IT, Williams S, Mustelin T, Stallcup WB. Differential phosphorylation of NG2 proteoglycan by ERK and PKCalpha helps balance cell proliferation and migration. J Cell Biol 2007, 178:155-165. 10.1083/jcb.200612084, 2064431, 17591920.
51. Goretzki L, Burg MA, Grako KA, Stallcup WB. High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan. J Biol Chem 1999, 274:16831-16837. 10.1074/jbc.274.24.16831, 10358027.
52. Makagiansar IT, Williams S, Dahlin-Huppe K, Fukushi J, Mustelin T, Stallcup WB. Phosphorylation of NG2 proteoglycan by protein kinase C-alpha regulates polarized membrane distribution and cell motility. J Biol Chem 2004, 279:55262-55270. 10.1074/jbc.M411045200, 15504744.
53. Fukushi J, Makagiansar IT, Stallcup WB. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. Mol Biol Cell 2004, 15:3580-3590. 10.1091/mbc.E04-03-0236, 491820, 15181153.
54. Satoh J, Kuroda Y. Differing effects of IFN beta vs IFN gamma in MS: gene expression in cultured astrocytes. Neurology 2001, 57:681-685.
55. Burger D, Molnarfi N, Weber MS, Brandt KJ, Benkhoucha M, Gruaz L, Chofflon M, Zamvil SS, Lalive PH. Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis. Proc Natl Acad Sci USA 2009, 106:4355-4359. 10.1073/pnas.0812183106, 2649955, 19255448.
56. Ponomarev ED, Maresz K, Tan Y, Dittel BN. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 2007, 27:10714-10721. 10.1523/JNEUROSCI.1922-07.2007, 17913905.
57. Reder AT, Genc K, Byskosh PV, Porrini AM. Monocyte activation in multiple sclerosis. Mult Scler 1998, 4:162-168.
58. Gao Q, Lu J, Huo Y, Baby N, Ling EA, Dheen ST. NG2, a member of chondroitin sulfate proteoglycans family mediates the inflammatory response of activated microglia. Neuroscience 2010, 165:386-394. 10.1016/j.neuroscience.2009.10.022, 19878709.